Published in Mol Cell Biol on February 01, 1986
Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus. J Virol (1987) 3.68
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J (1986) 2.62
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J (2002) 2.06
Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res (1992) 1.95
Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1987) 1.88
Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A (1993) 1.84
Molecular anatomy of viral persistence. J Virol (1991) 1.75
Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol (2007) 1.60
Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol (1998) 1.56
Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1989) 1.55
Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. J Virol (1997) 1.48
The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J Virol (2000) 1.45
The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Res (1994) 1.44
Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. Nucleic Acids Res (1989) 1.40
The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res (1991) 1.23
Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol (1999) 1.23
In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J Virol (1999) 1.22
Variations in the cytomegalovirus major immediate-early gene found by direct genomic sequencing. J Clin Microbiol (1992) 1.22
Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. Nucleic Acids Res (1996) 1.21
Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter. J Virol (1991) 1.20
Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc Natl Acad Sci U S A (1992) 1.17
Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol (2001) 1.16
Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J Virol (1995) 1.04
Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway. J Virol (2007) 1.01
Constitutive and anaerobically induced DNase-I-hypersensitive sites in the 5' region of the maize Adh1 gene. Proc Natl Acad Sci U S A (1987) 1.00
Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog (2010) 1.00
Rat cytomegalovirus major immediate-early enhancer switching results in altered growth characteristics. J Virol (2001) 0.92
Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts. J Exp Med (1989) 0.90
Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J Virol (1998) 0.84
Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process. PLoS One (2011) 0.84
Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines. Gut (1998) 0.80
Induction of matrix metalloprotease-1 gene expression by retinoic acid in the human pancreatic tumour cell line Dan-G. Br J Cancer (1999) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Chromosomal subunits in active genes have an altered conformation. Science (1976) 14.63
Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol Chem (1982) 11.91
Deletion mapping of DNA regions required for SV40 early region promoter function in vivo. J Mol Appl Genet (1982) 10.71
Transcriptional regulation of hemoglobin switching in chicken embryos. Mol Cell Biol (1981) 9.97
Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription. Nature (1985) 7.14
Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol (1984) 6.67
Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol (1982) 6.20
The chromatin structure of specific genes: I. Evidence for higher order domains of defined DNA sequence. Cell (1979) 5.83
Organization and expression of the immediate early genes of human cytomegalovirus. J Virol (1983) 5.74
Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell (1984) 5.61
Adenovirus E1a proteins repress transcription from the SV40 early promoter. Cell (1985) 5.59
Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA. Proc Natl Acad Sci U S A (1983) 5.21
DNAase I-hypersensitive sites of chromatin. Cell (1981) 5.06
Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 5.04
Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex. Proc Natl Acad Sci U S A (1982) 4.72
Transcription in human fibroblasts permissively infected by human cytomegalovirus strain AD169. Virology (1983) 4.58
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell (1984) 4.42
Human cytomegalovirus DNA: restriction enzyme cleavage maps and map locations for immediate-early, early, and late RNAs. Virology (1981) 4.12
Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest (1984) 3.86
Temporal order of chromatin structural changes associated with activation of the major chicken vitellogenin gene. Cell (1983) 3.62
Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells. Cell (1981) 3.61
Virus infection of murine teratocarcinoma stem cell lines. Cell (1977) 3.54
Structure and function of the adenovirus origin of replication. Cell (1984) 3.36
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Chromatin changes accompany immunoglobulin kappa gene activation: a potential control region within the gene. Nature (1982) 2.98
Alternative sets of DNase I-hypersensitive sites characterize the various functional states of the chicken lysozyme gene. Nature (1984) 2.69
Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro. J Cell Physiol (1975) 2.42
Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science (1984) 2.34
Transcriptional regulation of a herpes simplex virus immediate early gene is mediated through an enhancer-type sequence. EMBO J (1984) 2.29
A new selective agent for eukaryotic cloning vectors. Am J Trop Med Hyg (1980) 2.28
Size and complexity of human cytomegalovirus DNA. Virology (1978) 2.03
Replicative forms of human cytomegalovirus DNA with joined termini are found in permissively infected human cells but not in non-permissive Balb/c-3T3 mouse cells. J Gen Virol (1983) 2.00
High-affinity binding site for a specific nuclear protein in the human IgM gene. Nature (1985) 2.00
Evidence for non-spliced SV40 RNA in undifferentiated murine teratocarcinoma stem cells. Nature (1979) 1.99
Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169. J Virol (1982) 1.88
Human cytomegalovirus DNA: physical maps for restriction endonucleases BglII, hindIII and XbaI. J Gen Virol (1980) 1.84
Resistance of teratocarcinoma stem cells to infection with simian virus 40: early events. J Cell Physiol (1977) 1.71
Alteration of c-myc chromatin structure by avian leukosis virus integration. Nature (1984) 1.56
The appearance of DNase I hypersensitive sites at the 5' end of the late SV40 genes is correlated with the transcriptional switch. Nucleic Acids Res (1981) 1.50
Embryonal carcinoma stem cells lack a function required for virus replication. Nature (1980) 1.24
Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell differentiation. J Exp Med (1981) 1.21
Chromosomal subunits in active genes have an altered conformation. Science (1976) 14.63
Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNAase I. Cell (1980) 12.78
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (1986) 7.19
Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature (1982) 6.11
Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev (1997) 5.49
A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc Natl Acad Sci U S A (1986) 5.47
Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res (1987) 5.46
Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation. Nature (1981) 5.39
Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science (1985) 5.08
Hb switching in chickens. Cell (1980) 4.88
Looping versus linking: toward a model for long-distance gene activation. Genes Dev (1999) 4.63
Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res (1991) 4.60
Alpha-Globin-gene switching during the development of chicken embryos: expression and chromosome structure. Cell (1981) 4.47
Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (1985) 4.35
Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev (1995) 4.30
A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus. Genes Dev (1990) 4.30
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev (1992) 4.20
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol (1997) 4.17
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 4.11
Human fetal to adult hemoglobin switching: changes in chromatin structure of the beta-globin gene locus. Proc Natl Acad Sci U S A (1983) 4.05
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell (1997) 3.99
Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol (1989) 3.98
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (1985) 3.69
BEACHES: an observational system for assessing children's eating and physical activity behaviors and associated events. J Appl Behav Anal (1991) 3.61
Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc (1993) 3.57
Expression of the c-myb proto-oncogene during cellular proliferation. Nature (1986) 3.45
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Enhancers increase the probability but not the level of gene expression. Proc Natl Acad Sci U S A (1995) 3.44
Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev (1996) 3.40
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Transcription elongation and eukaryotic gene regulation. Oncogene (1990) 3.34
Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin locus. Genes Dev (2000) 3.27
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17
Molecular analysis of the human beta-globin locus activation region. Proc Natl Acad Sci U S A (1989) 3.17
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol Cell (2000) 3.03
Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol (1999) 3.02
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol (1987) 2.97
Sequence requirements for premature termination of transcription in the human c-myc gene. Cell (1988) 2.87
Correlates of physical activity at home in Mexican-American and Anglo-American preschool children. Health Psychol (1993) 2.74
Propagation of globin DNAase I-hypersensitive sites in absence of factors required for induction: a possible mechanism for determination. Cell (1982) 2.54
Interaction of HMG 14 and 17 with actively transcribed genes. Cell (1980) 2.52
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med (1990) 2.45
Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes. Proc Natl Acad Sci U S A (1999) 2.39
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol (2000) 2.36
Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas. Mol Cell Biol (1986) 2.34
The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus. Mol Cell (1998) 2.22
Participation of the human beta-globin locus control region in initiation of DNA replication. Science (1995) 2.18
Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3. Mol Cell Biol (1996) 2.17
The control of mammalian DNA replication: a brief history of space and timing. Cell (2001) 2.15
Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci U S A (1994) 2.14
Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer. EMBO J (1998) 2.13
A functional enhancer suppresses silencing of a transgene and prevents its localization close to centrometric heterochromatin. Cell (1999) 2.12
Transcriptional enhancers act in cis to suppress position-effect variegation. Genes Dev (1996) 2.09
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol (1999) 2.07
Post-transcriptional regulation of the chicken thymidine kinase gene. Nucleic Acids Res (1984) 2.02
Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00
The locus control region is necessary for gene expression in the human beta-globin locus but not the maintenance of an open chromatin structure in erythroid cells. Mol Cell Biol (1998) 1.99
Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood (1996) 1.98
Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol (2000) 1.98
Lineage-dependent transcription of globin genes. Cell (1974) 1.97
HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet (1997) 1.95
Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94
Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter. Proc Natl Acad Sci U S A (2001) 1.94
The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol (2000) 1.92
Do pathogens accelerate atherosclerosis? J Nutr (2001) 1.91
Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis (1987) 1.91
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90
Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169. J Virol (1982) 1.88
Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev (1994) 1.88
Analysis of methotrexate in human plasma by high-pressure liquid chromatography with fluorescence detection. Cancer Res (1977) 1.87
Accurate, TATA box-dependent polymerase III transcription from promoters of the c-myc gene in injected Xenopus oocytes. Genes Dev (1989) 1.85
Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region. Genes Dev (1992) 1.84
Activation of globin genes during chicken development. Cell (1981) 1.83
Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol (1993) 1.82
Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology (1993) 1.81
Chromatin structure and de novo methylation of sperm DNA: implications for activation of the paternal genome. Science (1985) 1.81
Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science (1987) 1.80
Radiographic findings of the National Cooperative Crohn's Disease Study. Gastroenterology (1979) 1.77
Television's influence on children's diet and physical activity. J Dev Behav Pediatr (1989) 1.77
Regulation of beta-globin gene expression: straightening out the locus. Curr Opin Genet Dev (1996) 1.76
Reconstitution of a MEC1-independent checkpoint in yeast by expression of a novel human fork head cDNA. Mol Cell Biol (1997) 1.75
Comparative structural and functional analysis of the olfactory receptor genes flanking the human and mouse beta-globin gene clusters. Proc Natl Acad Sci U S A (2000) 1.74
Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci U S A (1993) 1.73
Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex. J Virol (1997) 1.73
Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis (1998) 1.72
Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol Cell Biol (2001) 1.70
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol (1993) 1.68
Description and targeted deletion of 5' hypersensitive site 5 and 6 of the mouse beta-globin locus control region. Blood (1998) 1.68
Common mechanisms for the control of eukaryotic transcriptional elongation. Bioessays (1993) 1.68
Dynamic analysis of proviral induction and De Novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Mol Cell Biol (2000) 1.67